Sequential overlapping Gag protein-derived oligopeptides of human immunodeficiency virus type 1 (HIV-1) 22 to 24 amino acids long, were synthesized and tested in vitro for antiviral activity. Two synthetic peptides, one derived from the matrix protein p17 (NPGLLETSEGCRQ, amino acids 47 to 59) and one located in the capsid protein p24 (PAATLEEMMTA, amino acids 339 to 349) inhibited the production of infectious virus when added to HIV-l-infected cultures when used in the range of 20 to 200 μg/ml. As shown by thin section electron microscopy, peptide treatment resulted in the release of immature, deformed virus particles suggesting that the two peptides interfered with assembly and maturation. Other Gag protein-derived oligopeptides had little or no influence on virus production. To characterize further the functionally active regions we synthesized peptide derivatives with three consecutive amino acids substituted by alanine; they did not cause inhibition. Therefore the regions responsible for inhibition were located between amino acids 50 to 61 in pl7, and 342 to 350 in p24. These observations might lead to the development of a new antiviral strategy affecting the late stage of virus replication.
CohenE. A.,
GaudreauP.,
BrazeauP.,
LangelierY.1986; Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature; London: 321441–443
CollierN. C.,
KnoxK.,
SchlesingerM. J.1991; Inhibition of influenza virus formation by a peptide that corresponds to sequences in the cytoplasmic domain of the hemagglutinin. Virology 183:769–772
GaudreauP.,
ParadisH.,
LangelierY.,
BrazeauP.1990; Synthesis and inhibitory potency of peptides corresponding to the subunit 2 C-terminal region of Herpes virus ribonucleotide reductases. Journal of Medicinal Chemistry 33:723–730
GelderblomH. R.,
HausmannE. H. S.,
ÜzelM.,
PauliG.,
KochM. A.1987; Fine structure of lentiviruses. In Retroviral Proteases. Control of Maturation and Morphogenesis pp 159–180PearlL. H.
Edited by London: Macmillan Press;
GorelickR. J.,
NigidaS. M.,
BessJ. W.,
ArthurL. O.,
HendersonL. E.,
ReinA.1990; Non-infectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. Journal of Virology 64:3207–3211
GöttlingerH. G.,
SodroskiJ. G.,
HaseltineW. A.1989; Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences U.S.A.: 865781–5785
GöttlingerH. G.,
DorfmanT.,
SodroskiJ. G.,
HaseltineW. A.1991; Effects of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proceedings of the National Academy of Sciences U.S.A.: 883195–3199
GöttlingerJ. P.,
WegeH.,
PreissL.,
JentschK. D.1988; Detection of human immunodeficiency virus and other retroviruses in cell culture supernatants by a reverse transcriptase microassay. Journal of Virological Methods 19:161–168
HaistS.,
MärzJ.,
WolfH.,
ModrowS.1992; Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1 infected and uninfected humans. AIDS Research and Human Retroviruses 8:1909–1917
HendersonJ. E.,
SowderR. C.,
CopelandT. D.,
OroszlanS.,
BenevenisteR. E.1990; Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. Journal of Medical Primatology 19:411–419
HoglundS.,
ÜferstedtL.-G.,
NilsonA.,
ÜzelM.,
WinkelT.,
SkoglundU.,
GelderblomH. R.1991; Analysis of the assembly of the HIV core by electron microscope tomography. In Retroviral Proteases Control of Maturation and Morphogenesis pp 149–157PearlL. E.
Edited by London: Macmillan Press;
HuS.-L.,
TravisB. M.,
GarriguesJ.,
ZarlingJ. M.,
SridharP.,
DykersT.,
EichbergJ. W.,
AlpersC.1990; Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology 179:321–329
LandS.,
BeatonF.,
McPheeD. A.,
GustI. D.1989; Comparison of core antigen (p24) assay and reverse transcriptase activity for detection of human immunodeficiency virus type 1 replication. Journal of Clinical Microbiology 27:486–489
RatnerL.,
HaseltineW.,
PatarcaR.,
LivakK. J.,
StarcichB.,
JosephsS. F.,
DoraneE. R.,
RafalskiJ. A.,
WhitehornE. A.,
BaumeisterK.,
IvanoffL,
PearsonM. L.,
LautenbergerJ. A.,
PapasT. S.,
GhrayebJ.,
ChangN. T.,
GalloR. C.,
Wong-StaalF.1985; Complete nucleotide sequence of the AIDS virus, HTLV III. Nature; London: 313277–284
SchätzlH.,
GelderblomH. R.,
NitschkoH.,
Von Der HelmK.1991; Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor. Archives of Virology 120:71–81
SouthT. L.,
BlakeP. R.,
HareD. R.,
SummersM. F.1991; C-terminal retro viral-type zinc finger domain from the HIV-1 nucleo-capsid protein is structurally similar to the N-terminal zinc finger domain. Biochemistry 30:6342–6349
TelfordE.,
LankinenH.,
MarsdenH.1990; Inhibition of equine herpesvirus type 1 subtype 1-induced ribonucleotide reductase by the nonapeptide YAGAVVNDL. Journal of General Virology 71:1373–1378
TritchR. J.,
ChengY.-S.E.,
YinH. F.,
Erickson-VitanenS.1991; Mutagenesis of protease sites in the human immunodeficiency virus type 1 gag polyprotein. Journal of Virology 65:922–930
VernonS. K.,
MurthyS.,
WilhelmJ.,
ChandaP. K.,
KalyanN.,
LeeS.-G.,
HungP. P.1991; Ultrastructural characterization of human immunodeficiency virus type 1 Gag-containing particles assembled in a recombinant adenovirus vector system. Journal of General Virology 72:1243–1251
Von PoblotzkiA.,
WagnerR.,
NiedrigM.,
WannerG.,
WolfH.,
ModrowS.1993; Identification of a region in the pr55gag-polyprotein essential for HIV-1 particle formation. Virology 193:981–985
YuX.,
MatsudaZ.,
LeeT.-H.,
EssexM.1992; The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. Journal of Virology 66:4966–4971